Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 27, 1264-1269, July 1, 1967]
© 1967 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Silber, R.
Right arrow Articles by Friend, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Silber, R.
Right arrow Articles by Friend, C.

The Effect of a Murine Leukemia Virus on RNA Metabolism1

Robert Silber2, Bernard Goldstein, Ellen Berman, Julian Decter and Charlotte Friend

Department of Medicine, New York University School of Medicine, and Division of Microbiology, Sloan-Kettering Institute for Cancer Research, New York, New York 10016

RNA metabolism in the spleens of DBA/2 mice infected with a murine leukemia virus (Friend) was investigated. The spleen cells were tested in an in vitro system. Incorporation of uridine-14C into the RNA of spleen cells 4 days after the mice were inoculated with the virus was 4 times higher than that observed in normal spleen cell preparations. Subsequently, the incorporation of uridine-14C declined to control levels. RNA synthesis in both control and leukemic spleen cells was sensitive to the action of actinomycin D. RNA methylase increased in activity early after infection, reaching 3.5 times the control levels on the 5th post-inoculation day, and declining gradually to normal thereafter. Ribonuclease, on the other hand, declined to 25% of the normal activity by the 4th postinoculation day and remained at this level (or lower) throughout the course of the disease.

1 Publication #2 on "Enzyme Studies in Virus-Induced Neoplasms." This work was supported, in part, by National Cancer Institute Grants CA 06657, CA 02062, and CA 08748 and the Health Research Council of the City of New York, Contract number U-1096 II C 2.

2 Career Scientist, the Health Research Council of the City of New York.

Received 11/ 4/66. Accepted 3/14/67.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1967 by the American Association for Cancer Research.